Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Jazz Pharmaceuticals Price to Free Cash Flow Ratio 2010-2024 | JAZZ

Historical price to free cash flow ratio values for Jazz Pharmaceuticals (JAZZ) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Jazz Pharmaceuticals Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2024-06-12 111.02 7.56
2024-03-31 120.42 $14.69 8.20
2023-12-31 123.00 $14.82 8.30
2023-09-30 129.44 $18.15 7.13
2023-06-30 123.97 $20.46 6.06
2023-03-31 146.33 $21.04 6.95
2022-12-31 159.31 $19.87 8.02
2022-09-30 133.29 $17.56 7.59
2022-06-30 156.01 $14.93 10.45
2022-03-31 155.67 $10.86 14.33
2021-12-31 127.40 $12.58 10.13
2021-09-30 130.21 $12.68 10.27
2021-06-30 177.64 $12.97 13.69
2021-03-31 164.37 $15.70 10.47
2020-12-31 165.05 $15.65 10.54
2020-09-30 142.59 $14.12 10.10
2020-06-30 110.34 $15.33 7.20
2020-03-31 99.74 $14.49 6.88
2019-12-31 149.28 $13.04 11.45
2019-09-30 128.14 $14.99 8.55
2019-06-30 142.56 $13.57 10.51
2019-03-31 142.95 $14.23 10.05
2018-12-31 123.96 $13.50 9.18
2018-09-30 168.13 $13.13 12.81
2018-06-30 172.30 $11.81 14.59
2018-03-31 150.99 $10.82 13.96
2017-12-31 134.65 $10.83 12.43
2017-09-30 146.25 $10.52 13.91
2017-06-30 155.50 $9.71 16.02
2017-03-31 145.13 $9.67 15.01
2016-12-31 109.03 $9.42 11.58
2016-09-30 121.48 $8.38 14.49
2016-06-30 141.31 $8.94 15.81
2016-03-31 130.55 $8.95 14.59
2015-12-31 140.56 $7.87 17.86
2015-09-30 132.81 $7.94 16.72
2015-06-30 176.07 $7.19 24.50
2015-03-31 172.79 $6.12 28.23
2014-12-31 163.73 $5.93 27.61
2014-09-30 160.56 $5.23 30.71
2014-06-30 147.01 $5.39 27.27
2014-03-31 138.68 $4.52 30.69
2013-12-31 126.56 $4.52 27.98
2013-09-30 91.97 $5.04 18.26
2013-06-30 68.73 $3.62 18.99
2013-03-31 55.91 $4.75 11.76
2012-12-31 53.25 $4.05 13.15
2012-09-30 57.00 $3.24 17.57
2012-06-30 45.01 $3.52 12.79
2012-03-31 48.47 $3.09 15.68
2011-12-31 38.63 $3.21 12.03
2011-09-30 41.50 $2.90 14.31
2011-06-30 33.35 $2.31 14.43
2011-03-31 31.85 $2.54 12.54
2010-12-31 19.68 $2.05 9.61
2010-09-30 10.73 $1.06 10.08
2010-06-30 7.83 $0.67 11.75
2009-12-31 7.88 $-0.53 0.00
2009-09-30 8.02 $-0.39 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.999B $3.834B
Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus in the areas of neuroscience & oncology. It derives the majority of its revenues from its sleep disorder drugs' Xywav & Xyrem. Both drugs are approved for treating cataplexy & excessive daytime sleepiness in narcolepsy patients. Other drugs in the company's neuroscience portfolio include' Sunosi, Epidiolex & Sativex. Epidiolex is approved for treating seizures associated with two rare & severe forms of epilepsy' Lennox-Gastaut syndrome & Dravet syndrome. Sativex is approved in the U.K. & Canada as a treatment for symptom improvement in adult patients with moderate-to-severe spasticity due to multiple sclerosis. Jazz's oncology portfolio includes two drugs' Defitelio for the treatment hepatic veno-occlusive disease with renal or pulmonary dysfunction following hematopoietic stem cell transplantation & Vyxeos for the treatment of adults with two types of acute myeloid leukemia. It received approval for two new drugs' Zepzelca & Rylaze'.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $80.240B 32.62
Chugai Pharmaceutical (CHGCY) Japan $52.146B 23.31
Takeda Pharmaceutical (TAK) Japan $42.219B 8.55
Merck (MKGAF) Germany $24.879B 24.12
Astellas Pharma (ALPMY) Japan $17.717B 27.97
Sandoz Group AG (SDZNY) Switzerland $15.283B 0.00
Neurocrine Biosciences (NBIX) United States $13.548B 37.08
United Therapeutics (UTHR) United States $12.502B 13.33
Shionogi (SGIOY) Japan $11.482B 9.98
Catalent (CTLT) United States $10.126B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.479B 0.00
Revolution Medicines (RVMD) United States $6.598B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.091B 0.00
Ionis Pharmaceuticals (IONS) United States $6.058B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Summit Therapeutics (SMMT) United States $5.791B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.768B 0.00
Corcept Therapeutics (CORT) United States $3.398B 30.79
Arrowhead Pharmaceuticals (ARWR) United States $3.201B 0.00
PTC Therapeutics (PTCT) United States $2.889B 0.00
Dyne Therapeutics (DYN) United States $2.885B 0.00
Indivior (INDV) United States $2.323B 11.01
Recursion Pharmaceuticals (RXRX) United States $2.210B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.195B 12.47
Catalyst Pharmaceuticals (CPRX) United States $1.825B 17.76
NewAmsterdam Pharma (NAMS) Netherlands $1.782B 0.00
Evotec AG (EVO) Germany $1.710B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.606B 24.14
Ardelyx (ARDX) United States $1.557B 0.00
Soleno Therapeutics (SLNO) United States $1.542B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.463B 0.00
Xencor (XNCR) United States $1.358B 0.00
Pacira BioSciences (PCRX) United States $1.335B 12.69
BioCryst Pharmaceuticals (BCRX) United States $1.300B 0.00
4D Molecular Therapeutics (FDMT) United States $1.245B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.159B 0.00
Enliven Therapeutics (ELVN) United States $1.070B 0.00
Collegium Pharmaceutical (COLL) United States $1.043B 6.24
Relay Therapeutics (RLAY) United States $1.041B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.999B 15.56
Centessa Pharmaceuticals (CNTA) United Kingdom $0.975B 0.00
Cronos Group (CRON) Canada $0.955B 0.00
Cassava Sciences (SAVA) United States $0.915B 0.00
ARS Pharmaceuticals (SPRY) United States $0.882B 0.00
USANA Health Sciences (USNA) United States $0.879B 14.38
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.778B 0.00
Ocular Therapeutix (OCUL) United States $0.764B 0.00
ProKidney (PROK) United States $0.686B 0.00
Sage Therapeutics (SAGE) United States $0.653B 0.00
Lyell Immunopharma (LYEL) United States $0.653B 0.00
Harrow (HROW) United States $0.646B 0.00
Silence Therapeutics (SLN) United Kingdom $0.623B 0.00
Larimar Therapeutics (LRMR) United States $0.614B 0.00
Exscientia (EXAI) United Kingdom $0.613B 0.00
Lexeo Therapeutics (LXEO) United States $0.599B 0.00
Siga Technologies (SIGA) United States $0.560B 7.16
Savara (SVRA) United States $0.558B 0.00
Heron Therapeutics (HRTX) United States $0.551B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.548B 0.00
Esperion Therapeutics (ESPR) United States $0.548B 0.00
Bioventus (BVS) United States $0.537B 20.55
KalVista Pharmaceuticals (KALV) United States $0.521B 0.00
OmniAb (OABI) United States $0.518B 0.00
Verve Therapeutics (VERV) United States $0.469B 0.00
Altimmune (ALT) United States $0.452B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.420B 0.00
Tourmaline Bio (TRML) United States $0.415B 0.00
Korro Bio (KRRO) United States $0.395B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.364B 0.00
Black Diamond Therapeutics (BDTX) United States $0.351B 0.00
Organogenesis (ORGO) United States $0.350B 66.00
Xeris Biopharma Holdings (XERS) United States $0.332B 0.00
Fractyl Health (GUTS) United States $0.292B 0.00
Nature's Sunshine Products (NATR) United States $0.282B 17.94
Enanta Pharmaceuticals (ENTA) United States $0.282B 0.00
Century Therapeutics (IPSC) United States $0.270B 0.00
Foghorn Therapeutics (FHTX) United States $0.257B 0.00
Aquestive Therapeutics (AQST) United States $0.256B 0.00
Eliem Therapeutics (ELYM) United States $0.253B 0.00
Nanobiotix S.A (NBTX) France $0.251B 0.00
Akebia Therapeutics (AKBA) United States $0.243B 0.00
Nektar Therapeutics (NKTR) United States $0.237B 0.00
Acrivon Therapeutics (ACRV) United States $0.233B 0.00
Aldeyra Therapeutics (ALDX) United States $0.231B 0.00
ESSA Pharma (EPIX) Canada $0.231B 0.00
Avita Medical (RCEL) United States $0.228B 0.00
Pyxis Oncology (PYXS) United States $0.227B 0.00
Metagenomi (MGX) United States $0.227B 0.00
Profound Medical (PROF) Canada $0.222B 0.00
Prelude Therapeutics (PRLD) United States $0.221B 0.00
Innate Pharma SA (IPHYF) France $0.214B 0.00
Zevra Therapeutics (ZVRA) United States $0.208B 0.00
Incannex Healthcare (IXHL) Australia $0.205B 0.00
Cardiol Therapeutics (CRDL) Canada $0.203B 0.00
Adherex Technologies (FENC) United States $0.188B 229.00
Elite Pharmaceuticals (ELTP) United States $0.182B 17.00
Achieve Life Sciences (ACHV) Canada $0.179B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.175B 0.00
Galectin Therapeutics (GALT) United States $0.170B 0.00
Telomir Pharmaceuticals (TELO) United States $0.163B 0.00
Conduit Pharmaceuticals (CDT) United States $0.159B 0.00
Regulus Therapeutics (RGLS) United States $0.155B 0.00
Context Therapeutics (CNTX) United States $0.150B 0.00
MediWound (MDWD) Israel $0.149B 0.00
OptiNose (OPTN) United States $0.140B 0.00
CytoDyn (CYDY) United States $0.136B 0.00
VAXART, INC (VXRT) United States $0.134B 0.00
Karyopharm Therapeutics (KPTI) United States $0.128B 0.00
Journey Medical (DERM) United States $0.119B 0.00
Citius Pharmaceuticals (CTXR) United States $0.117B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.116B 7.77
FibroGen (FGEN) United States $0.115B 0.00
Assertio Holdings (ASRT) United States $0.099B 4.52
Relmada Therapeutics (RLMD) United States $0.091B 0.00
AlloVir (ALVR) United States $0.091B 0.00
PMV Pharmaceuticals (PMVP) United States $0.091B 0.00
ProPhase Labs (PRPH) United States $0.091B 0.00
Vivani Medical (VANI) United States $0.090B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.082B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.082B 0.00
SCYNEXIS (SCYX) United States $0.082B 1.15
Tempest Therapeutics (TPST) United States $0.069B 0.00
Champions Oncology (CSBR) United States $0.067B 0.00
Nutriband (NTRB) United States $0.067B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
Mural Oncology (MURA) Ireland $0.057B 0.00
Protara Therapeutics (TARA) United States $0.055B 0.00
BioLineRx (BLRX) Israel $0.052B 0.00
Carisma Therapeutics (CARM) United States $0.049B 0.00
DURECT (DRRX) United States $0.048B 0.00
Inotiv (NOTV) United States $0.045B 0.00
CASI Pharmaceuticals (CASI) China $0.043B 0.00
Lipocine (LPCN) United States $0.043B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Gain Therapeutics (GANX) United States $0.038B 0.00
Rafael Holdings (RFL) United States $0.037B 0.00
Surrozen (SRZN) United States $0.037B 0.00
NRx Pharmaceuticals (NRXP) United States $0.036B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.031B 0.00
BioVie (BIVI) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Viracta Therapeutics (VIRX) United States $0.026B 0.00
SHINECO (SISI) China $0.025B 0.00
Unicycive Therapeutics (UNCY) United States $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.025B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
JanOne (JAN) United States $0.023B 0.00
Minerva Neurosciences (NERV) United States $0.023B 0.00
Aptorum Group (APM) United Kingdom $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.021B 0.00
PolyPid (PYPD) Israel $0.020B 0.00
Iterum Therapeutics (ITRM) Ireland $0.020B 0.00
MEI Pharma (MEIP) United States $0.019B 0.73
Lyra Therapeutics (LYRA) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Jaguar Animal Health (JAGX) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Alaunos Therapeutics (TCRT) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
CERo Therapeutics Holdings (CERO) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.29
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 31.25